Rhizopus Infection in a Preterm Infant: A Novel Use of Posaconazole

Posaconazole is a triazole antifungal with activity against Rhizopus , but data on its use and pharmacokinetics in preterm infants are scarce. In this case, a 24 4/7-week neonate’s Rhizopus infection is successfully treated with debridement and combination antifungal therapy with amphotericin B, micafungin and enteral posaconazole. This is the first reported posaconazole use in a preterm neonate with Rhizopus .